Skip to main content
. 2020 Oct 9;137(13):1754–1764. doi: 10.1182/blood.2020006334

Figure 7.

Figure 7.

Pharmacological blockage of GCK inhibits MM cell proliferation and induces cell death. (A) RASWT MM cell lines (KMS12-PE, OPM2, LP-1, SKMM-2, and U266) and RASMut MM cell lines (MOLP-8, RPMI-8226, H929, MM.1S, and JJN3) were incubated with TL4-12 for 4 days. Cell proliferation was analyzed by MTS assay. Data represent the mean ± SD of n = 3 experiments. (B) RASWT LP-1 and K-RASG12A MM.1S cells were incubated with TL4-12 for 24 hours to analyze IKZF1, c-MYC, BCL-6, and P53 expression by western blotting. β-actin was detected as loading control. (C) Cells were treated by TL4-12 for 4 days to detect cell apoptosis with Annexin V and 7-AAD staining by flow cytometry assay. (D) MM.1S cells were treated with TL4-12 at the indicated concentrations with or without PS341 (1μM) for 24h. Lysates were analyzed by western blotting to compare the levels of IKZF1, c-MYC, and IRF-4. β-actin expression was probed for loading control. (E-F) N-RASG13D H929 cells were transduced using a lentivirus with control shRNA (shCNTL) or CRBN-shRNA (shCRBN). GFP-sorted cells were cultured in the presence of LEN or TL4-12 for 24 hours to analyze IKZF1, CRBN expression by western blotting (E); and for 4 days for cell proliferation detected by MTS assay (F). (G) Transduced and selected Tet-On-shGCK-MM.1S and Tet-On-shGCK-RPMI-8266 cells were cultured with LEN at the indicated concentrations with or without Dox 400 ng/mL for 3 days and cell proliferation was measured by MTS assay,